Cancer International Research Group – Trademark Portfolio
Entity Type: 99
Cancer International Research Group holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include TRIO TRANSLATIONAL RESEARCH IN ONCOLOGYA GLOBAL ALLIANCE, PROVIDING TREATMENTS OF THE FUTURE TO THE WORLD TODAY. The owner is based in Edmonton, Alberta T5K.
Suite 1100
9925-109 Street
Edmonton, Alberta T5K , CA
Showing of trademarks Trademarks
Trademark Classifications
Cancer International Research Group's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Cancer International Research Group have?
Cancer International Research Group has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Cancer International Research Group file in?
Cancer International Research Group files trademarks across 1 Nice Classification class. The most active classes are Class 42 (Computer & Scientific). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Cancer International Research Group's most well-known trademarks?
Cancer International Research Group's registered trademark portfolio includes well-known marks such as TRIO TRANSLATIONAL RESEARCH IN ONCOLOGYA GLOBAL ALLIANCE, PROVIDING TREATMENTS OF THE FUTURE TO THE WORLD TODAY. These are among 1 currently registered trademark in the portfolio.
What is Cancer International Research Group's trademark registration success rate?
Cancer International Research Group has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.